Publications

Internal Publications

Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor.
Koefoed K, Steinaa L, Søderberg JN, Kjær I, Jacobsen HJ, Meijer PJ, Haurum J, Jensen A, Kragh M, Andersen PS, Pedersen MW
Landes Bioscience, Nov/Dec, 2011.

Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans.
Poulsen TR, Jensen A, Haurum JS, Andersen PS
J Immunol., October, 2011. 

Preclinical pharmacokinetics and safety of Sym004: A synergistic antibody mixture directed against epidermal growth factor receptor.
Skartved NJ, Jacobsen HJ, Pedersen MW, Jensen PF, Sen JW, Hey A, Kragh M.
Clin Cancer Res., August, 2011.

Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use
Frandsen TP, Naested H, Rasmussen SK, Hauptig P, Wiberg FC, Rasmussen LK, Jensen AM, Persson P, Wikén M, Engström A, Jiang Y, Thorpe SJ, Förberg C, Tolstrup AB.
Biotechnol Bioeng., April, 2011. 

Capturing the Natural Diversity of the Human Antibody Response against Vaccinia Virus
Lantto J, Hansen MH, Rasmussen SK, Steinaa L, Poulsen TR, Duggan J, Dennis M, Naylor I, Easterbrook L, Bregenholt S, Haurum J, Jensen A.
J.Virology, February, 2011.

Development of Mass Spectrometry Based Techniques for the Identification and Determination of Compositional Variability in Recombinant Polyclonal Antibody Products
Persson P, Rasmussen LK, Holmberg E, Frandsen TP. Anal.Chem., 2010, 82, 7272-7282.

Single-Batch Production of Recombinant Human Polyclonal Antibodies
Nielsen LS, Baer A, Müller C, Gregersen K, Moenster NT, Rasmussen SK, Weilguny D, Tolstrup AB.
Mol Biotechnol, 2010, 45:3, 257-266.

Sym004: A Novel Synergistic Anti–Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy
Pedersen MW, Jacobsen HJ, Koefoed K, Hey A, Pyke C, Haurum JS and Kragh M.
Cancer Research 70, 588, January 15, 2010. 

Poulsen TR, Meijer PJ, Jensen A, Nielsen LS, Andersen PS.
J Immunol. 2007 Sep 15;179(6):3841-50.
 
Manufacture of recombinant polyclonal antibodies
Rasmussen SK, Rasmussen LK, Weilguny D, Tolstrup AB.
Biotechnol Lett. 2007, Feb 20.
 
Extensive restrictions in the VH sequence usage of the human antibody response against the Rhesus D antigen
Andersen PS, Haahr-Hansen M, Coljee VW, Hinnerfeldt FR, Varming K, Bregenholt S, Haurum JS.
Mol Immunol. 2007 Jan;44(4):412-22. Epub 2006, Apr 3. 
 
Reduced susceptibility of recombinant polyclonal antibodies to inhibitory anti-variable domain antibody responses
Klitgaard JL, Coljee VW, Andersen PS, Rasmussen LK, Nielsen LS, Haurum JS, Bregenholt S.
J Immunol. 2006 Sep 15;177(6):3782-90.
 
Expert Opin Biol Ther. 2006 Sep;6(9):905-12. Review.
 
Haurum JS
Drug Discov Today. 2006 Jul;11(13-14):655-660.
 
Recombinant Human Polyclonal Antibodies: A New Class of Therapeutic Antibodies Against Viral Infections
Bregenholt S, Jensen A, Lantto J, Hyldig S, Haurum JS
Curr Pharm Des. 2006;12(16):2007-2015.
 

Allergen-specific polyclonal antibodies reduce allergic disease in a mouse model of allergic asthma
Moerch U, Haahr Hansen M, Vest Hansen NJ, Rasmussen LK, Oleksiewicz MB, Frandsen TP, Haurum JS, Bregenholt S.
Int Arch Allergy Immunol. 2006;140(3):261-269.

Production of target-specific recombinant human polyclonal antibodies in mammalian cells
Wiberg FC, Rasmussen SK, Frandsen TP, Rasmussen LK, Tengbjerg K, Coljee VW, Sharon J, Yang CY, Bregenholt S, Nielsen LS, Haurum JS, Tolstrup AB.
Biotechnol Bioeng. 2006 Jun 5;94(2):396-405. 

 
Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing
Meijer PJ, Andersen PS, Haahr Hansen M, Steinaa L, Jensen A, Lantto J, Oleksiewicz MB, Tengbjerg K, Poulsen TR, Coljee VW, Bregenholt S, Haurum JS, Nielsen LS.
J Mol Biol. 2006 May 5;358(3):764-72. Epub 2006 Mar 2. 
 
Protein Expression and Purification, 2005; 41:373-377.
 
IDrugs. 2005 May;8(5):404-9. Review.
 
Pathogen-specific recombinant human polyclonal antibodies: biodefence applications
Bregenholt S, Haurum J.
Expert Opin Biol Ther. 2004 Mar;4(3):387-96. Review.
 

 

External Publications

Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs.
Marina Zaitseva, Senta M. Kapnick, Clement A. Meseda, Elizabeth Shotwell, Lisa R. King, Jody Manischewitz, John Scott, Shantha Kodihalli, Michael Merchlinsky, Henriette Nielsen, Johan Lantto, Jerry P. Weir, and Hana Golding
J. Virol., 2011, doi:10.1128/JVI.00121-11

Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura.
Stasi R.
Curr Opin Mol Ther. 2010 Dec;12(6):734-40.

Symphogen internalized EGFR
Hansen, S.
www.BioCentury.com, 2010 January 25; A5-A6.


Symphogen, Origen develop antibody-producing chickens 
Carroll, J.
www.fiercebiotech.com, 2009 March 6. 

Chen L, Liebman MA, Teodorescu-Frumosu S, Schnitzler AC, Sharon J.
Immunol Lett. 2003 Aug 5;88(2):135-140. 
 
Polyclonal Fab phage display libraries with a high percentage of diverse clones to Cryptosporidium parvum glycoproteins
Chen L, Williams BR, Yang CY, Cevallos AM, Bhat N, Ward H, Sharon J.
Int J Parasitol. 2003 Mar;33(3):281-291.
 
Construction of polyclonal antibody libraries using phage display
Sharon J, Sompuram SR, Yang CY, Williams BR, Sarantopoulos S.
Methods Mol Biol. 2002;178:101-112. Review.
 
Recombinant polyclonal antibody libraries
Sharon J, Sarantopoulos S, Den W, Kao CY, Baecher-Allan CM, Santora KE, Sompuram SR, Petersen-Mahrt S, Williams BR.
Comb Chem High Throughput Screen. 2000 Jun;3(3):185-196. Review.
 
Santora KE, Sarantopoulos S, Den W, Petersen-Mahrt S, Sompuram SR, Sharon J.
Comb Chem High Throughput Screen. 2000 Feb;3(1):51-57. 
 
Generation of a polyclonal Fab phage display library to the protozoan parasite Cryptosporidium parvum
Baecher-Allan CM, Santora K, Sarantopoulos S, Den W, Sompuram SR, Sharon J, Cevallos AM, Bhat N, Ward H.
Comb Chem High Throughput Screen. 1999 Dec;2(6):319-325. 
 
J Immunol Methods. 1999 Jan 1;222(1-2):45-57.